Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119862) titled 'Research on implantation safety, data security, ethical risks, and countermeasures for invasive brain-computer interfaces' on March 4.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Beijing Tiantan Hospital, Capital Medical University

Condition: Parkinson's disease/Epilepsy

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-02-05

Target Sample Size: Standard-treatment cohort:100;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=289266

Published by HT Digital Content Services with permission from H...